Sensitivity in Cost Effectiveness Analyses

Slides:



Advertisements
Similar presentations
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlikeLicense. Your use of this material constitutes acceptance of that license.
Advertisements

Maternal and child nutrition
NEURAL TUBE DEFECT ROLE OF FOLIC ACID
ADDRESSING ADOLESCENT ANAEMIA We Must Act Now Dr. Sheila Vir.
Bayesian Network and Influence Diagram A Guide to Construction And Analysis.
FOLIC ACID It’s never too early.... What is folic acid? B vitamin essential for healthy development of unborn baby’s spine, brain and skull can help reduce.
Medical Statistics Joan Morris Professor of Medical Statistics Goldsmiths Lecture 2014.
Cost-Effectiveness Using Decision-Analytic Models
Folic Acid and Pregnancy Data from the Pregnancy Risk Assessment Monitoring System (PRAMS)
Julie Garden-Robinson Food and Nutrition Specialist Module by Bridget Curley Program Assistant.
Exploring uncertainty in cost effectiveness analysis NICE International and HITAP copyright © 2013 Francis Ruiz NICE International (acknowledgements to:
Objective Today Demonstrate an understanding of the nutritional considerations during pregnancy.
1 Chapter 12 Value of Information. 2 Chapter 12, Value of information Learning Objectives: Probability and Perfect Information The Expected Value of Information.
Decision and cost-effectiveness analysis: Understanding sensitivity analysis Advanced Training in Clinical Research Lecture 5 UCSF Department of Epidemiology.
BAYESIAN POSTERIOR DISTRIBUTIONS FOR PROBABILISTIC SENSITIVITY ANALYSIS Gordon B. Hazen and Min Huang, IEMS Department, Northwestern University, Evanston.
The role of economic modelling – a brief introduction Francis Ruiz NICE International © NICE 2014.
Recommendations for Conducting Cost Effectiveness: Elements of the Reference Case Ciaran S. Phibbs, Ph.D. February 25, 2009.
Health care decision making Dr. Giampiero Favato presented at the University Program in Health Economics Ragusa, June 2008.
Schneider Institute for Health Policy Heller School Brandeis University September Donald S. Shepard, Ph.D. Schneider Institute for Health Policy.
Maternal Nutrition during Pregnancy and Lactation BY PROFESSOR JIB ADINMA DEPARTMENT OF OBS/GYN NNAMDI AZIKIWE UNIVERSITY TEACHING HOSPITAL NNEWI, NIGERIA.
Sources of Uncertainty and Current Practices for Addressing Them: Exposure Perspective Clarence W. Murray, III, Ph.D. Center for Food Safety and Applied.
What Nutrients Might a Pregnant Woman Need More Than a Non-Pregnant Woman?
Economic Evaluations, Briefly… CHSC 433 Module 6/Chapter 13 UIC School of Public Health L. Michele Issel, PhD, R N.
Cost-Effectiveness Problem l You have a $1.5 billion budget to spend on any combination of these programs:
Healthy Before Pregnancy March of Dimes NC Preconception Health Campaign.
Prevention of Birth Defects: Periconceptional Multivitamins with Folic Acid (MVF) Jill Moore (1) Ken Rosenberg, MD, MPH (1,2) Al Sandoval, MS, MBA (2)
Folic Acid : A “B” Vitamin for a Healthier YOU ! Alabama Department of Public Health’s Alabama Folic Acid Council and the University of South Alabama's.
Evidence Evaluation & Methods Workgroup: Developing a Decision Analysis Model Lisa A. Prosser, PhD, MS September 23, 2011.
Model Based DSS Creating Information Under Conditions of Uncertainty and Complexity Interface MODEL BASE DATA BASE MBMSDBMS DATA WAREHOUSING ON LINE ANALYTICAL.
Managing Organizations Informed decision making as a prerequisite for success Action Vision Mission Organizational Context Policies, Goals, and Objectives.
UNIT 5 SEMINAR NS 220 Module 5: Vitamins and Health.
Michiel Van den Hof Dalhousie University Halifax, Nova Scotia.
Engineering Economic Analysis Canadian Edition
Decision and Cost-Effectiveness Analysis: Understanding Sensitivity Analysis Training in Clinical Research DCEA Lecture 5 UCSF Dept. of Epidemiology &
Basic Economic Analysis David Epstein, Centre for Health Economics, York.
Validation / citations. Validation u Expert review of model structure u Expert review of basic code implementation u Reproduce original inputs u Correctly.
Decision Analysis Dr M G Dawes Centre for Evidence Based Medicine.
Spina Bifida Association of America Mission: To promote the prevention of spina bifida and to enhance the lives of all affected Local Group Members 59.
MBA7020_01.ppt/June 13, 2005/Page 1 Georgia State University - Confidential MBA 7020 Business Analysis Foundations Introduction - Why Business Analysis.
Economic evaluation of health programmes Department of Epidemiology, Biostatistics and Occupational Health Class no. 23: Nov 17, 2008.
Articulating the Value of Consumer Engagement 2 – 3:30 pm ET July 25, 2013.
What is the Minimum Effective Dose of Folic Acid for Preventing NTDs? James L. Mills, M.D., M.S. Caroline Signore, M.D. NICHD.
Introduction to Probabilistic Analysis Introduction to Probabilistic Analysis The third phase of the cycle incorporates uncertainty into the analysis.
Cost-Effectiveness and Outcomes Research Setting value to what we do.
Spina bifida. Spina bifida is one of a class of birth defects called neural tube defects. The spinal cord and nerves are exposed on the surface of the.
TM Assessing the Impact of Fortification on the Epidemiology of Neural Tube Defects FDA Advisory Committee for Reproductive Health Drugs December 15, 2003.
Iodine Supplementation: an overview Kate Jolly Professor of Public Health & Primary Care University of Birmingham.
1 Edward Broughton, PhD., MPH Director of Research and Evaluation, USAID Health Care Improvement Project, University Research Co., LLC
Figure 1 Overview of Markov model for infected total hip arthroplasty
Colorectal Cancer Screening Guidelines
Introduction Out-of-hospital cardiac arrest (OHCA) is the sudden cessation of the heart in an out of hospital setting. In the United States, the incidence.
Global burden of diseases
Lisa L. Massi Lindsey, Ph.D. Michigan State University
Dobson|DaVanzo & Associates, LLC
Markov model structure
A Systematic Review of Interventions to Increase Awareness, Knowledge, and Folic Acid Consumption Before and During Pregnancy Corina Mihaela Chivu, MD,
From: Low-Molecular-Weight Heparins Compared with Unfractionated Heparin for Treatment of Acute Deep Venous Thrombosis: A Cost-Effectiveness Analysis Ann.
Fertility Treatment.
For a Healthy pregnancy
ANENCEPHALY Ayling Sanjaya.
Using the Coronary Artery Calcium Score to Guide Statin Therapy
Health care decision making
Cost-Effectiveness of Strategies for Diagnosing Pulmonary Embolism Among Emergency Department Patients Presenting With Undifferentiated Symptoms  Ram.
DR. AMAL ELSHABRAWY MD. OBSTETRICS AND GYNECOLOGY ASSOCIATE PROFESSOR, AIN SHAMS UNIVERSITY.
Monte Carlo Simulation
FIGURE 1 Predicted risk of NTDs by RBC folate concentrations by folic acid source among nonpregnant women aged 12– FIGURE 1 Predicted risk of NTDs.
Research shows that women can reduce their risks of having a baby with a neural tube defect by taking folic acid, or folate, which is a B vitamin. Folic.
Flow diagram illustrating diabetes outcomes in the randomly assigned treatment of folic acid and vitamins B6 and B12 of the WAFACS. A total of 1,190 participants.
Tornado diagram of one-way sensitivity analyses on key model parameters. Tornado diagram of one-way sensitivity analyses on key model parameters. Parameters.
Presentation transcript:

Sensitivity in Cost Effectiveness Analyses Sensitivity of a CEA on prevention strategies against Neural Tube Defects using DPL software. Radboud Duintjer Tebbens

Contents Objectives Problem Description The Model Implementation and Deterministic Results Sensitivity Analysis Probabilistic Model Conclusions 1/13/2019 Sensitivity in CEA's

Objectives Exploring the possibilities of DPL for sensitivity analyses Getting familiar with Cost Effectiveness Analyses How can sensitivity analyses on CEA’s be improved? 1/13/2019 Sensitivity in CEA's

Problem Description What is a Cost Effectiveness Analysis? Analysis that compares health interventions using C/E ratio C/E ratio = Incremental Cost/Incremental Effectiveness = Incremental Cost / Incremental QALY’s QALY: Quality-Adjusted Life Year 1 QALY = 1 year in full health 0 QALY = 1 year dead 1/13/2019 Sensitivity in CEA's

Problem Description (2) The CEA on Neural Tube Defects (NTD’s) considers 5 health programs for prevention of NTD’s on newborns: 1. No Program (baseline) 2. Supplementation: education program to stimulate women aged 15-45 to take Vitamin Supplements 3,4&5. Fortification with folic acid: a rule that forces food producers to fortify cereals with folic acid, 0.14 , 0.35 or 0.70 mg per 100g of cereals The CEA on neural tube defects is described in the appendix of the book: Cost-effectiveness in Health and Medicine, M.R. Gold et. al, Oxford University Press 1996 1/13/2019 Sensitivity in CEA's

Problem Description (3) Adverse Effect in Fortification Programs: intakes of more than 1.0 mg of folic acid can cause delayed diagnosis of vitamin B12 deficiency which can lead to neurological complications, mostly by elderly persons 1/13/2019 Sensitivity in CEA's

The Model Simple deterministic model that: Calculates the number of babies born with NTD with each program Calculates the number of Adverse Effects caused by any of the programs Adds costs of the various programs and their health outcomes Uses expert judgment outcomes to evaluate the number of QALY’s gained compared to the baseline case ‘no program’. 1/13/2019 Sensitivity in CEA's

The Model (2) Important Uncertain Parameters: parameter value sensitivity range QALY’s per NTD 12.591 5 -20 Costs per NTD 180972.8 160 000 - 200 000 QALY’s per Adverse Effect 0.31 0.20 - 0.40 Costs per Adverse Effect 3897.38 3500 - 4300 pNTD0.4+ 0.000035 0.000021-0.000049 pNTD0.4- 0.000085 -- pOAdvEff 0.000023 0.000007-0.000047 pBegSupp 0.15 0.0 -1.0 1/13/2019 Sensitivity in CEA's

Model (3) pNTD0.4+ is the probability that a women aged 15-45 who consumes at least 0.4 mg of folic acid daily will have an NTD affected pregnancy. pNTD0.4+ is the probability that a women aged 15-45 who consumes less than 0.4 mg of folic acid daily will have an NTD affected pregnancy. The difference between these variable accounts for the number of prevented NTD’s by the health intervention. pOAdveff, the probability that someone who is not a woman aged 15-45 and who consumes more than 1.0 mg of folic acid daily, eventually quantifies the occurrence of neurological complications 1/13/2019 Sensitivity in CEA's

Implementation and Deterministic Results Straightforward Influence Diagram with 1 Decision Node: Program Many Value Nodes containing all model parameters Objective function to be minimized: Incremental C/E = Costs/QALY’s Gained NB: I used Costs instead of Incremental Costs 1/13/2019 Sensitivity in CEA's

Implementation and Deterministic Results (2) Program Costs(M$) QALY’s lost Incremental C/E No Program 710 49 398 - Suppl. 724 45 642 195 089 Fort. 0.14 706 48 373 688 821 Fort. 0.35 636 43 119 101 333 Fort. 0.70 503 32 144 31 106 1/13/2019 Sensitivity in CEA's

Sensitivity Analysis Univariate: Rainbow Diagrams or Tornado Diagrams Many Univariate Sensitivity Analyses at once: Tornado Diagrams Multivariate? (See accompanying DPL file: NTDdeterm.da) 1/13/2019 Sensitivity in CEA's

Probabilistic Model Not conceptually very clear Use of Risk Profiles and probability distributions, but very basic No improvement for sensitivity visualization (See accompanying DPL file: NTDprob.da) 1/13/2019 Sensitivity in CEA's

Conclusions DPL is good for a first look at sensitivity of a model on its parameters. First look at CEA on NTD prevention shows that the decision based on the C/E ratio is very little sensitive to most uncertain parameters, even though the cost and health outcomes are quite sensitive to them. 1/13/2019 Sensitivity in CEA's

Conclusions (2) Multivariate sensitivity analyses for CEA’s? It would be interesting to look at uncertainty analysis for CEA’s, taking into consideration the (joint) probability distribution of the uncertain parameters (but is it necessary?) 1/13/2019 Sensitivity in CEA's